Pedro Plans Rubio

Pedro Plans-Rubió is member of the College of Physicians of Barcelona, Spain. MD, PhD, MSc in Health Economics, and MSc in Research Methods. Responsible for Health Registries at the Public Health Agency, Department of Health of Catalonia, Spain, until 2025. Specialized in Preventive Medicine and Public Health. Specialized in Labor Medicine. Expert of the European Commission for assessing public health and health economics projects. Member of the Group of Prioritization of Treatments (GIP), Heath Emergency Preparedness and Response (HERA), European Commission. Member of the non-communicable diseases risk factor Collaboration (NCD-RisC) research group. Member of the CIBER of Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain (until 2025). Editor-in Chief of Section “Vaccine Advancement, Efficacy and Safety” of the journal Vaccines. Editor of the journal Pharmacoeconomics Open. Associate Editor of Section "Cancer Immunity and Immunotherapy" of the journal Frontiers in Immunology and the journal Frontiers in Oncology. Dr. Plans-Rubió has developed and participated in epidemiological and seroepidemiologic studies of measles, mumps, rubella, pertussis, tetanus, diphtheria, polio, hepatitis A, hepatitis B, hepatitis C, tuberculosis, SARS-CoV-2 and influenza. He has authored and co-authored peer-reviewed publications on the evaluation of vaccines and vaccination programs, the epidemiology of infectious diseases, the epidemiology of factors associated with chronic diseases, the economic evaluation of drugs, and the strategies of prevention and control of vaccine-preventable diseases. Dr. Plans-Rubió is author of the book “Application of the cost-effectiveness of medicines and health programs in the health planning” (Elsevier).